Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Cancer Biology & Therapy|January 27, 2012
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancerJill P Smith, John F Harms, Gail L Matters, et al.ACS Nano|February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivoBrian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.Nucleic Acid Therapeutics|October 19, 2016
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaGary A Clawson, Thomas Abraham, Weihua Pan, et al.Plos One|September 29, 2017
"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinomaGary A Clawson, Gail L Matters, Ping Xin, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancerWelley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|March 16, 2021
Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblastsKaren M Bussard, Christopher M Gigliotti, Bernadette M Adair, et al.Nature|February 9, 2018
Isomer depletion as experimental evidence of nuclear excitation by electron captureC J Chiara, J J Carroll, M P Carpenter, et al.Contemporary Clinical Trials|August 31, 2024
EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND): Protocol and Baseline Data for a Randomized TrialJashalynn German, Qing Yang, Daniel Hatch, et al.Annals of Internal Medicine|June 22, 2026
Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care : A Pragmatic, Randomized, Effectiveness-Implementation TrialMatthew J Crowley, Allison A Lewinski, Qing Yang, et al.Pageof 10